Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 02 2022
Historique:
received: 12 07 2021
accepted: 18 01 2022
entrez: 11 2 2022
pubmed: 12 2 2022
medline: 8 3 2022
Statut: epublish

Résumé

Autologous cell replacement therapy for inherited metabolic disorders requires the correction of the underlying genetic mutation in patient's cells. An unexplored alternative for females affected from X-linked diseases is the clonal selection of cells randomly silencing the X-chromosome containing the mutant allele, without in vivo or ex vivo genome editing. In this report, we have isolated dermal fibroblasts from a female patient affected of ornithine transcarbamylase deficiency and obtained clones based on inactivation status of either maternally or paternally inherited X chromosome, followed by differentiation to hepatocytes. Hepatocyte-like cells derived from these clones display indistinct features characteristic of hepatocytes, but express either the mutant or wild type OTC allele depending on X-inactivation pattern. When clonally derived hepatocyte-like cells were transplanted into FRG

Identifiants

pubmed: 35145162
doi: 10.1038/s41598-022-06184-w
pii: 10.1038/s41598-022-06184-w
pmc: PMC8831560
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2308

Informations de copyright

© 2022. The Author(s).

Références

Cell Transplant. 2012;21(1):1-10
pubmed: 21457616
J Cell Physiol. 1993 Mar;154(3):506-10
pubmed: 8436599
J Genet Genomics. 2015 May 20;42(5):181-94
pubmed: 26059767
Clin Genet. 1998 Oct;54(4):349-53
pubmed: 9831349
Mol Genet Metab. 2014 Sep-Oct;113(1-2):127-30
pubmed: 25135652
Mol Ther. 2009 Aug;17(8):1340-6
pubmed: 19384294
Arch Neurol. 2010 Feb;67(2):148-53
pubmed: 20142522
Cell Stem Cell. 2014 Mar 6;14(3):370-84
pubmed: 24582927
J Lab Clin Med. 1992 Dec;120(6):836-50
pubmed: 1453106
J Biol Chem. 1996 Feb 16;271(7):3639-46
pubmed: 8631974
Pediatr Clin North Am. 2018 Apr;65(2):231-246
pubmed: 29502911
Nature. 2012 Mar 28;483(7391):608-12
pubmed: 22460906
J Inherit Metab Dis. 2007 Apr;30(2):217-26
pubmed: 17334707
J Inherit Metab Dis. 2019 Nov;42(6):1192-1230
pubmed: 30982989
Mol Genet Metab Rep. 2020 May 08;23:100598
pubmed: 32420033
J Med Genet. 1995 Sep;32(9):680-8
pubmed: 8544185
J Biol Chem. 1980 Nov 10;255(21):10248-55
pubmed: 7430121
Am J Hum Genet. 1996 Jun;58(6):1101-8
pubmed: 8651285
J Control Release. 2018 Sep 10;285:1-11
pubmed: 29966689
Virchows Arch. 2018 Jun;472(6):1029-1039
pubmed: 29623395
Toxicol Sci. 2016 Jul;152(1):214-29
pubmed: 27208088
Nat Biotechnol. 2007 Aug;25(8):903-10
pubmed: 17664939
Proteins. 2000 Jun 1;39(4):271-7
pubmed: 10813810
Hum Gene Ther. 2002 Jan 1;13(1):163-75
pubmed: 11779420
J Hepatol. 2019 Jun;70(6):1049-1050
pubmed: 31005337
J Clin Invest. 2008 Jan;118(1):333-41
pubmed: 18097474
Stem Cell Res Ther. 2016 Jul 27;7(1):96
pubmed: 27460218
J Inherit Metab Dis. 2019 Nov;42(6):1064-1076
pubmed: 30714172
Hum Mutat. 1996;8(4):373-4
pubmed: 8956045
J Pediatr. 2002 Mar;140(3):321-7
pubmed: 11953730
Nature. 1979 Sep 27;281(5729):311-3
pubmed: 551278
Sci Rep. 2015 Nov 23;5:16884
pubmed: 26592180
Orphanet J Rare Dis. 2017 Jun 15;12(1):111
pubmed: 28619060
Am J Hum Genet. 1992 Dec;51(6):1229-39
pubmed: 1281384
JIMD Rep. 2021 May 04;60(1):88-95
pubmed: 34258144
Am J Hum Genet. 2006 Sep;79(3):493-9
pubmed: 16909387
Proc Natl Acad Sci U S A. 1989 Jun;86(11):4142-6
pubmed: 2471197
Stem Cell Res Ther. 2020 Apr 10;11(1):154
pubmed: 32276654
Mol Ther. 2012 Oct;20(10):1981-7
pubmed: 22871666
Cell Transplant. 2021 Jan-Dec;30:9636897211019025
pubmed: 34044601
Science. 1984 Nov 9;226(4675):698-700
pubmed: 6494904
Sci Rep. 2019 Nov 29;9(1):17978
pubmed: 31784643
Stem Cell Res Ther. 2015 Dec 12;6:246
pubmed: 26652177
Stem Cell Res Ther. 2019 Nov 4;10(1):317
pubmed: 31685034

Auteurs

Ramon Santamaria (R)

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.

Maria Ballester (M)

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.

Guillem Garcia-Llorens (G)

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Biochemistry and Molecular Biology Department, Universidad de Valencia, Valencia, Spain.

Francisco Martinez (F)

Genetics Unit, Instituto de Investigación Sanitaria La Fe, Hospital Universitari i Politècnic La Fe, 46026, Valencia, Spain.

Marina Blazquez (M)

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.

Carmen Ribes-Koninckx (C)

Coeliac Disease and Inmunopathology Research Unit, Instituto de Investigación Sanitaria La Fe, Pediatric Gastroenterology, Hospital Universitari i Politècnic La Fe, 46026, Valencia, Spain.

Jose V Castell (JV)

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Biochemistry and Molecular Biology Department, Universidad de Valencia, Valencia, Spain.

Torsten Wuestefeld (T)

Laboratory for In Vivo Genetics & Gene Therapy, Genome Institute of Singapore, A*STAR & National Cancer Centre Singapore, School of Biological Science, SingHealth & Adj. Ass.-Prof. Nanyang Technological University, 60 Biopolis Street, #02-01 Genome, Singapore, 138672, Singapore.

Roque Bort (R)

Experimental Hepatology Unit, Instituto de Investigación Sanitaria La Fe, CIBERehd, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. bort_ber@gva.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH